# Ultrastructural and Molecular Analysis of Vascular Smooth Muscle Cells During the Switch from a Physiological to a Pathological Phenotype

## TL;DR

This study explores how vascular smooth muscle cells change from a normal to a disease-related state, which could lead to better treatments for atherosclerosis.

## Contribution

The study provides new insights into the ultrastructural and molecular changes in vascular smooth muscle cells during pathological transitions.

## Key findings

- VSMCs showed actin cytoskeleton remodeling and increased autophagic vacuoles during the synthetic phenotype transition.
- Calcified VSMCs exhibited calcium microcrystal deposition and upregulated RUNX-2, indicating an osteoblast-like shift.
- Phenotypic changes were confirmed through α-SMA and galectin-3 expression patterns using immunofluorescence.

## Abstract

Background/Objectives: Under physiological conditions, vascular smooth muscle cells (VSMCs) are in a quiescent contractile state, but under pathological conditions, such as atherosclerosis, they change their phenotype to synthetic, characterized by increased proliferation, migration, and production of an extracellular matrix. Furthermore, VSMCs can undergo calcification, switching to an osteoblast-like phenotype, contributing to plaque instability. Methods: In this study, we analyzed the phenotypic changes in VSMCs during the transition from a physiological to a pathological state, a key process in the progression of atherosclerosis, using confocal and transmission electron microscopy, real-time PCR, and intracellular calcium quantification. Results: Confocal and transmission electron microscopy revealed a prominent remodeling of the actin cytoskeleton, increasing autophagic vacuoles in synthetic VSMCs and the deposition of calcium microcrystals in calcified cells. Immunofluorescence analysis revealed differential expression of α-SMA (contractile marker) and galectin-3 (synthetic marker), confirming the phenotypic changes. Real-time PCR further validated these changes, showing upregulation of RUNX-2, a marker of osteogenic transition, in calcified VSMCs. Conclusions: This study highlights the dynamic plasticity of VSMCs and their role in atherosclerosis progression. Understanding the characteristics of these phenotypic transitions can help develop targeted therapies to mitigate vascular calcification and plaque instability, potentially countering cardiovascular disease.